|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
TransForm Pharmaceuticals, Inc. And University of South Florida Announce Collaboration To Improve Drug Performance Through Co-crystals
10/19/2005 5:11:06 PM
TransForm Pharmaceuticals, Inc. (TransForm) today announced a major collaborative effort with University of South Florida (USF) in Tampa, FL in the design and discovery of pharmaceutical co-crystal structures to enhance drug properties. Pharmaceutical co-crystals, a newly recognized category of small molecule pharmaceutical physical forms, can impact the physical-chemical properties of a drug by improving properties such as solubility, dissolution rate, stability and processing. A review of the field of pharmaceutical co-crystals entitled "Crystal Engineering of the Composition of Pharmaceutical Phases. Do Pharmaceutical Co-crystals Represent a New Path to Improved Medicines?" is currently available on-line at www.rsc.org and will appear in print in Chemical Communications, a publication of the Royal Society of Chemistry, in Issue 17 scheduled to publish on September 7, 2004.
|
|
|
|
|
|
|
|
|
|
|